دوره 13، شماره 6 - ( 5-1394 )
جلد 13 شماره 6 صفحات 336-327 |
برگشت به فهرست نسخه ها
چکیده: (2191 مشاهده)
آدنومیوز یک بیماری فراگیر است که در طول دوران باروری، زنان را درگیر می کند. در ده سال گذشته فرضیه های پاتوژنتیک متفاوتی جهت توضیح شروع و گسترش این بیماری شرح داده شده است. این مقاله تلاش دارد که مهمترین مکانیزم های درگیر در آدنومیوز را شرح دهد تا ارتباط بین آدنومیوز و ناباروری مشخص گردد. یک جستجو در PubMed جهت مقالات انگلیسی زبان با استفاده از واژه های :MeSH آدنومیوز، ناباروری، درمان و پاتوژنزیس انجام گرفت. اگر چه که علت واقعی آدنومیوز مشخص نیست ولی فرضیه های زیادی ارائه شده است. ما مهمترین فرضیه ها را که حاوی اثرات این بیماری بر ناباروری زنان بود را آنالیز کردیم. درک بهتر پاتوژنهای درگیر در آدنومیوز نشان داد که آدنومیوز می تواند زنان جوان را تحت تاثیر قرار داده و اثر بزرگ بر باروری آنها با مکانیزم های مختلف داشته باشد. فهم این مکانیزم ها کمک بزرگی به مشخص کردن درک مفید بودن درمان های موجود می کند.
نوع مطالعه: Original Article |
فهرست منابع
1. Azziz R. Adenomyosis: current perspectives. Obstet Gynecol Clin North Am 1989; 16: 221-235.
2. Benson RC, Sneeden VD. Adenomyosis: a reappraisal of symptomatology. Am J Obstet Gynecol 1958; 76: 1044-1057. [DOI:10.1016/0002-9378(58)90186-8]
3. Bird CC, McElin TW, Manalo-Estrella P The elusive adenomyosis of the uterus-revisited. Am J Obstet Gynecol 1972; 112: 583-593. [DOI:10.1016/0002-9378(72)90781-8]
4. Lee NC, Dicker RC, Rubin GL, Ory HW. Confirmation of the preoperative diagnoses for hysterectomy. Am J Obstet Gynecol. 1984; 150: 283-287. [DOI:10.1016/S0002-9378(84)90366-1]
5. Barrier BF, Malinowski MJ, Dick EJ Jr, Hubbard GB, Bates GW. Adenomyosis in the baboon is associated with primary infertility. Fertil Steril 2004; 82: 1091-1094. [DOI:10.1016/j.fertnstert.2003.11.065]
6. Brosens I, Derwig I, Brosens J, Fusi L, Benagiano G, Pijnenborg R. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? Hum Reprod 2010; 25: 569-574. [DOI:10.1093/humrep/dep474]
7. Matsumoto Y, Iwasaka T, Yamasaki F, Sugimori H. Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol 1999; 94: 71-77.
8. Bergeron C, Amant F, Ferenczy A. Pathology and physiology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006; 20: 511-521. [DOI:10.1016/j.bpobgyn.2006.01.016]
9. Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet 2009; 280: 529-538. [DOI:10.1007/s00404-009-1191-0]
10. Garcia-Segura LM. Aromatase in the brain: not just for reproduction anymore. J Neuroendocrinol 2008; 20: 705-712. [DOI:10.1111/j.1365-2826.2008.01713.x]
11. Leyendecker G, Kunz G, Kissler S, Wildt L. Adenomyosis and reproduction. Best Pract Res Clin Obstet Gynaecol 2006; 20: 523-546. [DOI:10.1016/j.bpobgyn.2006.01.008]
12. Leyendecker G, Kunz G, Noe M, Herbertz M, Mall G. Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod Update 1998; 4: 752-762. [DOI:10.1093/humupd/4.5.752]
13. Leyendecker G, Kunz G, Wildt L, Beil D, Deininger H. Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum Reprod 1996; 11: 1542-1551. [DOI:10.1093/oxfordjournals.humrep.a019435]
14. Leyendecker G, Kunz G, Herbertz M, Beil D, Huppert P, Mall G, et al. Uterine peristaltic activity and the development of endometriosis. Ann NY Acad Sci 2004; 1034: 338-355. [DOI:10.1196/annals.1335.036]
15. Kunz G, Noe M, Herbertz M, Leyendecker G. Uterine peristalsis during the follicular phase of the menstrual cycle. EVects of oestrogen, antioestrogen and oxytocin. Hum Reprod Update 1998; 4: 647-654. [DOI:10.1093/humupd/4.5.647]
16. Yang G, Im HJ, Wang JH. Repetitive mechanical stretching modulates IL-1beta induced COX-2, MMP-1 expression, and PGE2 production in human patellar tendon Wbroblasts. Gene 2005; 363: 166-172. [DOI:10.1016/j.gene.2005.08.006]
17. Hadjiargyrou M, Ahrens W, Rubin CT. Temporal expression of the chondrogenic and angiogenic growth factor CYR61 during fracture repair. J Bone Miner Res 2000; 15: 1014-1023. [DOI:10.1359/jbmr.2000.15.6.1014]
18. Zingg HH, Rozen F, Chu K, Larcher A, Arslan A, Richard S, et al. Oxytocin and oxytocin receptor gene expres-sion in the uterus. Recent Progr Hormone Res 1995; 50: 255-273.
19. Mizumoto Y, Furuya K, Makimura N, Mitsui C, Seki K, Kimura T, et al. Gene expression of oxytocin receptor in human eutopic endometrial tissues. Adv Exp Med Biol 1995; 395: 491-493.
20. Leyendecker G, Herbertz M, Kunz G, Mall G. Endometriosis results from the dislocation of basal endometrium. Hum Reprod 2002; 17: 2725-2736. [DOI:10.1093/humrep/17.10.2725]
21. Kunz G, Beil D, Huppert P, Noe M, Kissler S, Leyendecker G. Adenomyosis in endometriosis-prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod 2005; 20: 2309-2316. [DOI:10.1093/humrep/dei021]
22. Leyendecker G. Endometriosis is an entity with extreme pleiomorphism. Hum Reprod 2000; 15: 4-7. [DOI:10.1093/humrep/15.1.4]
23. Counseller VS. Endometriosis: a clinical and surgical review. Am J Obstet Gynecol 1938; 36: 877-886. [DOI:10.1016/S0002-9378(38)90579-4]
24. Wang F, Li H, Yang Z, Du X, Cui M, Wen Z. Expression of interleukin-10 in patients with adenomyosis. Fertil Steril 2009; 91: 1681-1685. [DOI:10.1016/j.fertnstert.2008.02.164]
25. Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999; 11: 803-811. [DOI:10.1093/intimm/11.5.803]
26. Devlieger R, D'Hooghe T, Timmerman D. Uterine adenomyosis in the infertility clinic. Hum Reprod Update. 2003; 9: 139-147. [DOI:10.1093/humupd/dmg010]
27. Ota H, Igarashi S, Hatazawa J, Tanaka T. Is adenomyosis an immune disease? Hum Reprod Update 1998; 4: 360-367. [DOI:10.1093/humupd/4.4.360]
28. Ota H, Igarashi S, Hatazawa J, Tanaka T. Immunohistochemical assessment of superoxide dismutase expression in endometriosis and adenomyosis. Fertil Steril 1999; 72: 129-134. [DOI:10.1016/S0015-0282(99)00152-1]
29. Ota H, Igarashi S, Kato N, Tanaka T. Aberrant expression of glutathione peroxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil Steril 2000; 74: 313-318. [DOI:10.1016/S0015-0282(00)00638-5]
30. Ota H, Igarashi S, Sasaki M, Tanaka T. Distribution of cyclo-oxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 2001; 16: 561-566. [DOI:10.1093/humrep/16.3.561]
31. Ota H, Igarashi S, Tanaka T. Xanthine oxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil Steril 2001; 75: 785-790. [DOI:10.1016/S0015-0282(01)01670-3]
32. Yang L, Hu Y, Hou Y. Effects of 17beta-estradiol on the maturation, nuclear factor kappa B p65 and functions of murine spleen CD11c-positive dendritic cells. Mol Immunol 2006; 43: 357-366. [DOI:10.1016/j.molimm.2005.02.012]
33. Xiao Y, Sun X, Yang X, Zhang J, Xue Q, Cai B, et al. Leukemia inhibitory factor is dysregulated in the endometrium and uterine flushing fluid of patients with adenomyosis during implantation window. Fertil Steril 2010; 94: 85-89. [DOI:10.1016/j.fertnstert.2009.03.012]
34. Noda Y, Matsumoto H, Umaoka Y, Tatsumi K, Kishi J, Mori T. Involvement of superoxide radicals in the mouse two-cell block. Mol Reprod Dev 1991; 28: 356-360. [DOI:10.1002/mrd.1080280408]
35. Chwalisz K, Garfield RE. Role of nitric oxide in implantation and menstruation. Hum Reprod 2000; 15S3: 96-111.
36. Ota H1, Igarashi S, Hatazawa J, Tanaka T. Endothelial nitric oxide synthase in the endometrium during the menstrual cycle in patients with endometriosis and adenomyosis. Fertil Steril 1998; 69: 303-308. [DOI:10.1016/S0015-0282(97)00478-0]
37. Salvemini D, et al. Role of nitric oxide in the regulation of cyclooxygenase. In: Moncada S, Feelish M, Busse R. Biology of Nitric Oxide. Nitric oxide in implantation and menstruation. Biochemistry and Immunology. Portland Press, London; 1995: 304-309.
38. Van Buren GA, Yang DS, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 1992; 167: 828-833. [DOI:10.1016/S0002-9378(11)91597-X]
39. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994; 91: 5212-5216. [DOI:10.1073/pnas.91.11.5212]
40. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Up-regulation of nitric oxide synthase by oestradiol in human aortic endothelial cells. FEBS Lett 1995; 360: 291-293. [DOI:10.1016/0014-5793(95)00124-R]
41. Brosens I, Derwig I, Brosens J, Fusi L, Benagiano G, Pijnenborg R. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? Hum Reprod 2010; 25: 569-574. [DOI:10.1093/humrep/dep474]
42. Cullinan-Bove K, Koos RD. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen- induced increases in uterine capillary permeability and growth. Endocrinology 1993; 133: 829-837. [DOI:10.1210/endo.133.2.8344219]
43. Li T, Li YG, Pu DM. Matrix metalloproteinase-2 and -9 expressions correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest 2006; 62: 229-235. [DOI:10.1159/000094426]
44. Goteri G, Lucarini G, Montik N, Zizzi A, Stramazzotti D, Fabris G, et al. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1alpha (HIF-1alpha), and microvessel density in endometrial tissue in women with adenomyosis. Int J Gynecol Pathol 2009; 28: 157-163. [DOI:10.1097/PGP.0b013e318182c2be]
45. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 2000; 60: 3183-3190.
46. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993; 91: 2235-2243. [DOI:10.1172/JCI116450]
47. Kissler S, Hamscho N, Zangos S, Wiegratz I, Schlichter S, Menzel C, et al. Uterotubal transport disorder in adenomyosis and endometriosis-a cause for infertility. BJOG 2006; 113: 902-908. [DOI:10.1111/j.1471-0528.2006.00970.x]
48. Juang CM, Chou P, Yen MS, Twu NF, Horng HC, Hsu WL. Adenomyosis and risk of preterm delivery. BJOG 2007; 114: 165-169. [DOI:10.1111/j.1471-0528.2006.01186.x]
49. Lockwood CJ, Kuczynski E. Markers of risk for preterm delivery. J Perinat Med 1999; 27: 5-20. [DOI:10.1515/JPM.1999.001]
50. Fidel PL Jr, Romero R, Wolf N, Cutright J, Ramirez M, Araneda H, et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994; 170: 1467-1475. [DOI:10.1016/S0002-9378(13)90489-0]
51. Kaga N, Katsuki Y, Obata M, Shibutani Y. Repeated administration of low-dose lipopolysaccharide induced preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am J Obstet Gynecol 1996; 174: 754-759. [DOI:10.1016/S0002-9378(96)70460-X]
52. Jenkinson PC, Anderson D, Gangolli SD. Malformations induced in cultured rat embryos by enzimically generated active oxygen species. Teratog Carinog Mutagen. 1986; 6: 547-54. [DOI:10.1002/tcm.1770060608]
53. Igarashi M. A new therapy for pelvic endometriosis and uterine adenomyosis: local effect of vaginal and intrauterine danazol application. Asia Oceania J Obstet Gynaecol 1990; 16: 1-12. [DOI:10.1111/j.1447-0756.1990.tb00207.x]
54. Kim ML, Seong SJ. Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases. Obstet Gynecol Sci 2013; 56: 67-75. [DOI:10.5468/OGS.2013.56.2.67]
55. Kimura F, Takahashi K, Takebayashi K, Fujiwara M, Kita N, Noda Y, et al. Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist. Fertil Steril 2007; 87: 1468. [DOI:10.1016/j.fertnstert.2006.09.010]
56. Badawy AM, Elnashar AM, Mosbah AA. Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. Acta Obstet Gynecol Scand. 2012; 91: 489-495. [DOI:10.1111/j.1600-0412.2012.01350.x]
57. Jang D, Kim MD, Lee SJ, Kim IJ, Park SI, Won JY,, et al. The effect of uterine artery embolization on premenstrual symptoms in patients with symptomatic fibroids or adenomyosis. J Vasc Interv Radiol 2014; 25: 833-838. [DOI:10.1016/j.jvir.2014.01.036]
58. Pron G, Mocarski E, Bennett J, Vilos G, Common A, Vanderburgh L, et al. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol 2005; 105: 67-76. [DOI:10.1097/01.AOG.0000149156.07061.1f]
59. Zhang X, Li K, Xie B, He M, He J, Zhang L Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound. Int J Gynaecol Obstet 2014; 124: 207-211. [DOI:10.1016/j.ijgo.2013.08.022]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |